Handelsbanken Fonder’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,600
| Closed | -$99K | – | 1548 |
|
|
2025
Q1 | $99K | Hold |
44,600
| – | – | ﹤0.01% | 1520 |
|
|
2024
Q4 | $243K | Hold |
44,600
| – | – | ﹤0.01% | 1491 |
|
|
2024
Q3 | $371K | Buy |
44,600
+11,700
| +36% | +$97.3K | ﹤0.01% | 1348 |
|
|
2024
Q2 | $236K | Buy |
32,900
+7,400
| +29% | +$53.1K | ﹤0.01% | 1455 |
|
|
2024
Q1 | $221K | Hold |
25,500
| – | – | ﹤0.01% | 1492 |
|
|
2023
Q4 | $167K | Buy |
25,500
+3,400
| +15% | +$22.3K | ﹤0.01% | 1527 |
|
|
2023
Q3 | $221K | Hold |
22,100
| – | – | ﹤0.01% | 1435 |
|
|
2023
Q2 | $275K | Buy |
22,100
+2,800
| +15% | +$34.8K | ﹤0.01% | 1378 |
|
|
2023
Q1 | $270K | Hold |
19,300
| – | – | ﹤0.01% | 1338 |
|
|
2022
Q4 | $276K | Buy |
19,300
+2,800
| +17% | +$40K | ﹤0.01% | 1291 |
|
|
2022
Q3 | $421K | Hold |
16,500
| – | – | ﹤0.01% | 1062 |
|
|
2022
Q2 | $469K | Buy |
16,500
+300
| +2% | +$8.53K | ﹤0.01% | 1062 |
|
|
2022
Q1 | $571K | Hold |
16,200
| – | – | ﹤0.01% | 1106 |
|
|
2021
Q4 | $679K | Buy |
+16,200
| New | +$679K | ﹤0.01% | 1139 |
|